Bio-Rad Laboratories
(BIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 1,958,700 | 1,304,900 | 640,000 | 2,553,100 | 1,921,000 |
| Accounts payable and accrued liabilities | -1,511,400 | -993,900 | -488,000 | -2,058,200 | -1,531,300 |
| Other Working Capital | 347,500 | 231,800 | 121,900 | 349,000 | 268,400 |
| Other Operating Activity | -427,500 | -296,400 | -144,000 | -388,700 | -327,100 |
| Operating Cash Flow | $367,300 | $246,400 | $129,900 | $455,200 | $331,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 174,700 | 184,200 | 37,300 | 28,700 | 16,300 |
| PPE Investments | -111,700 | -80,000 | -34,400 | -165,500 | -122,600 |
| Net Acquisitions | -218,500 | -216,700 | N/A | N/A | -23,400 |
| Other Investing Activity | 0 | 0 | 0 | -23,400 | 0 |
| Investing Cash Flow | $-155,500 | $-112,500 | $2,900 | $-160,200 | $-129,700 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -300 | -300 | -100 | -400 | -400 |
| Common Stock Issued | 11,900 | 8,500 | 4,300 | 19,200 | 15,300 |
| Common Stock Repurchased | -295,500 | -242,100 | -101,900 | -203,600 | -203,600 |
| Other Financing Activity | -2,600 | -100 | 0 | -34,000 | -3,900 |
| Financing Cash Flow | $-286,500 | $-234,000 | $-97,700 | $-218,800 | $-192,600 |
| Exchange Rate Effect | -16,900 | -18,000 | -1,800 | 9,200 | -900 |
| Beginning Cash Position | 489,800 | 489,800 | 489,800 | 404,400 | 404,400 |
| End Cash Position | 398,200 | 371,700 | 523,100 | 489,800 | 412,200 |
| Net Cash Flow | $-91,600 | $-118,100 | $33,300 | $85,400 | $7,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | 367,300 | 246,400 | 129,900 | 455,200 | 331,000 |
| Capital Expenditure | -111,800 | -80,100 | -34,400 | -165,600 | -122,700 |
| Free Cash Flow | 255,500 | 166,300 | 95,500 | 289,600 | 208,300 |